iShares Genomics Immunology and Healthcare ETF (IDNA) Stock Price, Quote, News & History

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD82,502.49−0.07%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Premium

iShares Genomics Immunology and Healthcare ETF (IDNA) Stock Price, Quote, News & History

IDNAARCA

Trade with Public

$42.08

1.664.11%

Last update: Oct 9, 4:00 PM

OverviewNews Holdings Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

307.68M

Fund Score

Key Statistics

Open

$40.52

High

$42.13

52 Wk High

$43.44

AUM

307.68M

Dividend

$0.29

Ex-Div Date

Jun 15, 2026

Volume

128.39K

Market Cap

$35.82B

Mgmt Fee

0.47%

P/E Ratio

16.12

Prev. Close

$40.42

Low

$42.13

52 Wk Low

$23.90

Shares Out

5.85M

Yield

0.72%

Div. Freq

Avg. Volume Daily

169.40K

Beta

0.94

Avg. Expense Ratio

0.47%

P/B Ratio

3.96

Recent iShares Genomics Immunology and Healthcare ETF News

Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.

Chandrima Sanyal

Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For

MRK, MRNA's cancer vaccine breakthrough could revive the mRNA trade, putting biotech and genomics ETFs back in focus.

Chandrima Sanyal

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025.

Akanksha Bakshi

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for rare tumor treatments and immediate revenue growth.

Lekha Gupta

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health Organization on Monday, marking a dramatic acceleration of President Donald Trump's executive order to withdraw from the global health body.

Kaustubh Bagalkote

FAQ

How do I buy iShares Genomics Immunology and Healthcare ETF (IDNA) stock?

You can purchase shares of iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) through any online brokerage.

View our list of the best stock brokerages

Who are iShares Genomics Immunology and Healthcare ETF (IDNA) competitors?

There are no as such competitors for iShares Genomics Immunology and Healthcare ETF.

What is the forecast, or price target, for iShares Genomics Immunology and Healthcare ETF (IDNA) stock?

There is no analysis for iShares Genomics Immunology and Healthcare ETF to provide a consensus price target.

What is the current price for iShares Genomics Immunology and Healthcare ETF (IDNA)?

The stock price for iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA) is $42.08 last updated October 9, 2026 at 4:00 PM EDT.

Does iShares Genomics Immunology and Healthcare ETF (IDNA) pay a dividend?

There are no upcoming dividends for iShares Genomics Immunology and Healthcare ETF.

When is iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) reporting earnings?

iShares Genomics Immunology and Healthcare ETF does not have any upcoming earnings scheduled.

Is iShares Genomics Immunology and Healthcare ETF (IDNA) going to split?

There is no upcoming split for iShares Genomics Immunology and Healthcare ETF.

Key Statistics

Open

$40.52

High

$42.13

52 Wk High

$43.44

AUM

307.68M

Dividend

$0.29

Ex-Div Date

Jun 15, 2026

Volume

128.39K

Market Cap

$35.82B

Mgmt Fee

0.47%

P/E Ratio

16.12

Prev. Close

$40.42

Low

$42.13

52 Wk Low

$23.90

Shares Out

5.85M

Yield

0.72%

Div. Freq

Avg. Volume Daily

169.40K

Beta

0.94

Avg. Expense Ratio

0.47%

P/B Ratio

3.96

About iShares Genomics Immunology and Healthcare ETF

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Mid Cap Growth
Fund Inception	Jun 11, 2019
Managers	Peter Sietsema Jennifer Hsui Steven White Matt Waldron
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Top ETF Holdings

Symbol	Name	Share %
SG	Bayer Ag	3.45%
MRNA	Moderna	11.2%
TK	Takeda Pharmaceutical ...	3.33%
RVMD	Revolution Medicines I...	3.89%
TWST	Twist Bioscience Corp.	7.66%
INCY	Incyte Corp.	3.23%
REGN	Regeneron Pharmaceutic...	3.26%
GMAB	Genmab	3.99%
MRK	Merck & Co. Inc.	3.36%
IOVA	Iovance Biotherapeutic...	4.88%

Key Statistics

Open

$40.52

High

$42.13

52 Wk High

$43.44

AUM

307.68M

Dividend

$0.29

Ex-Div Date

Jun 15, 2026

Volume

128.39K

Market Cap

$35.82B

Mgmt Fee

0.47%

P/E Ratio

16.12

Prev. Close

$40.42

Low

$42.13

52 Wk Low

$23.90

Shares Out

5.85M

Yield

0.72%

Div. Freq

Avg. Volume Daily

169.40K

Beta

0.94

Avg. Expense Ratio

0.47%

P/B Ratio

3.96

Recent iShares Genomics Immunology and Healthcare ETF News

Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.

Chandrima Sanyal

Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For

MRK, MRNA's cancer vaccine breakthrough could revive the mRNA trade, putting biotech and genomics ETFs back in focus.

Chandrima Sanyal

Genetic Data From 23andMe Ends Up With This Company In $256 Million Deal

Regeneron (REGN) to acquire 23andMe for $256 million, plans to maintain consumer services and uphold privacy policies. Deal expected to close Q3 2025.

Akanksha Bakshi

Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion

Merck & Company, Inc. (MRK) to acquire SpringWorks Therapeutics, Inc. (SWTX) for $47/share in cash, creating synergies for rare tumor treatments and immediate revenue growth.

Lekha Gupta

Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?

Kaustubh Bagalkote

FAQ

How do I buy iShares Genomics Immunology and Healthcare ETF (IDNA) stock?

You can purchase shares of iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) through any online brokerage.

View our list of the best stock brokerages

Who are iShares Genomics Immunology and Healthcare ETF (IDNA) competitors?

There are no as such competitors for iShares Genomics Immunology and Healthcare ETF.

What is the forecast, or price target, for iShares Genomics Immunology and Healthcare ETF (IDNA) stock?

There is no analysis for iShares Genomics Immunology and Healthcare ETF to provide a consensus price target.

What is the current price for iShares Genomics Immunology and Healthcare ETF (IDNA)?

The stock price for iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA) is $42.08 last updated October 9, 2026 at 4:00 PM EDT.

Does iShares Genomics Immunology and Healthcare ETF (IDNA) pay a dividend?

There are no upcoming dividends for iShares Genomics Immunology and Healthcare ETF.

When is iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) reporting earnings?

iShares Genomics Immunology and Healthcare ETF does not have any upcoming earnings scheduled.

Is iShares Genomics Immunology and Healthcare ETF (IDNA) going to split?

There is no upcoming split for iShares Genomics Immunology and Healthcare ETF.

Key Statistics

Open

$40.52

High

$42.13

52 Wk High

$43.44

AUM

307.68M

Dividend

$0.29

Ex-Div Date

Jun 15, 2026

Volume

128.39K

Market Cap

$35.82B

Mgmt Fee

0.47%

P/E Ratio

16.12

Prev. Close

$40.42

Low

$42.13

52 Wk Low

$23.90

Shares Out

5.85M

Yield

0.72%

Div. Freq

Avg. Volume Daily

169.40K

Beta

0.94

Avg. Expense Ratio

0.47%

P/B Ratio

3.96

About iShares Genomics Immunology and Healthcare ETF

Sector

N/A

Industry

N/A

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Mid Cap Growth
Fund Inception	Jun 11, 2019
Managers	Peter Sietsema Jennifer Hsui Steven White Matt Waldron
Definition	Most of the stocks in this equity fund have average financial performance and average growth potential

Investment Policy

Top ETF Holdings

Symbol	Name	Share %
SG	Bayer Ag	3.45%
MRNA	Moderna	11.2%
TK	Takeda Pharmaceutical ...	3.33%
RVMD	Revolution Medicines I...	3.89%
TWST	Twist Bioscience Corp.	7.66%
INCY	Incyte Corp.	3.23%
REGN	Regeneron Pharmaceutic...	3.26%
GMAB	Genmab	3.99%
MRK	Merck & Co. Inc.	3.36%
IOVA	Iovance Biotherapeutic...	4.88%

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Sector

Healthcare

Region

AUM

307.68M

Fund Score